Alcanza Clinical Research acquires Kansas City Research Institute to enhance clinical research capabilities
Acquiring Company
Alcanza
Acquired Company
Kansas City Research Institute
Lake MaryKansas CityBiotechnologyHealth CareBiotechnologyHealth CareMedicalDescription
Alcanza Clinical Research, a mission-focused investigator site network, has completed the acquisition of Kansas City Research Institute (KCRI), a Phase II-IV clinical research site based in Kansas City, MO. This strategic acquisition enables Alcanza to offer more trial participation opportunities to underrepresented patient populations in the Midwest region, especially with a focus on therapeutic specializations in gastroenterology, gastrointestinal oncology, hepatology, and metabolic diseases.
Quick answer
Alcanza is acquiring Kansas City Research Institute, announced May 1, 2024. Alcanza is based in Lake Mary, Florida, United States.
- How much did Alcanza pay for Kansas City Research Institute?
- The deal value was not disclosed.
- What does Alcanza do?
- Alcanza Clinical Research is a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations.
- Where are Alcanza and Kansas City Research Institute based?
- Alcanza is based in Lake Mary, Florida, United States. Kansas City Research Institute is based in Kansas City, Missouri, United States.
- Who are the decision-makers at Alcanza?
- Fundz holds 1 contact at Alcanza. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
Who to call at Alcanza, and when
When Alcanza changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alcanza raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alcanza, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alcanza. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alcanza makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kansas City Research Institute?
Kansas City Research Institute was acquired by Alcanza, based in Lake Mary. The deal was reported on May 1, 2024. Alcanza Clinical Research is a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. Alcanza is privately held and operates in Biotechnology.
When did Alcanza acquire Kansas City Research Institute?
Alcanza's acquisition of Kansas City Research Institute was reported on May 1, 2024. Alcanza Clinical Research, a mission-focused investigator site network, has completed the acquisition of Kansas City Research Institute (KCRI), a Phase II-IV clinical research site based in Kansas City, MO. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kansas City Research Institute do?
It is privately held, operating in Biotechnology, and is based in Kansas City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.